Tectonic Therapeutic TECX
NASDAQ TECX
$22.14 +0.31 (+1.44%)
As of: Oct 21, 2026 · 9:40 AM EDT

Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023)

Updated

Tectonic Therapeutic (TECX) posted Non-Current Debt of $15.36 million for Q1 2023, up 2.2% from $15.02 million a year earlier and up 0.5% from the prior quarter.

Analysis

Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Tectonic Therapeutic's Non-Current Debt came in at $15.28 million, up 2.2% from FY2021.

  • In prior years, Tectonic Therapeutic's Non-Current Debt was $14.95 million in FY2021.
  • According to Business Quant data, Non-Current Debt for the three prior quarters was $15.28 million (Q4 2022), $15.21 million (Q3 2022) and $15.1 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn 37.34 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn 62.48 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 60.50 Bn
10 Tectonic Therapeutic 419.86 Mn -566.37 Mn - -96,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.36 Mn
Dec 31, 2022 15.28 Mn
Sep 30, 2022 15.21 Mn
Jun 30, 2022 15.10 Mn
Mar 31, 2022 15.02 Mn
Dec 31, 2021 14.95 Mn
API Access

Tectonic Therapeutic Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TECX&period=max&api_key=YOUR_API_KEY